Significant Accounting Policies (Tables)

6 Months Ended

12 Months Ended

Apr. 30, 2013

Oct. 31, 2012

Impairment Charges Reduced Carrying Amounts Respective Long-Lived Assets

The impairment charges reduced the carrying amounts of the respective long-lived assets as follows:


	Year Ended October 31,
In thousands	2012			2011			2010
Carrying value of long-lived assets	$	7,933		$	13,592		$	14,865
Less: Impairment charges		(7,234	)		(12,228	)		(11,657	)

Fair value of long-lived assets	$	699		$	1,364		$	3,208

Revenues in Consolidated Statements of Operations

Revenues in the Consolidated Statements of Operations include the following:


	Year Ended October 31,
In thousands	2012		2011		2010
Product sales, net	$	1,993,668	$	1,926,941	$	1,825,807
Royalty income		19,571		26,120		11,813

	$	2,013,239	$	1,953,061	$	1,837,620

Reconciliation of Denominator of Each Net Loss Per Share

The table below sets forth the reconciliation of the denominator of each net loss per share calculation for the second quarter and first half ended April 30, 2013 and 2012:

Second Quarter Ended

April 30,

First Half Ended

April 30,

In thousands

2013

2012

2013

2012

Shares used in computing basic net loss per share

166,815

163,953

166,282

163,655

Dilutive effect of stock options and restricted stock⁽¹⁾

—

Dilutive effect of stock warrants⁽¹⁾

—

Shares used in computing diluted net loss per share

166,815

163,953

166,282

163,655

⁽¹⁾

For the second quarter ended April 30, 2013 and 2012, the shares used in computing diluted net loss per share do not include 4,389,000 and 4,080,000, respectively, of dilutive stock options and shares of restricted stock, nor 18,074,000 and 14,321,000, respectively, of dilutive warrant shares as the effect is anti-dilutive given the Company’s loss. For the second quarter ended April 30, 2013 and 2012, additional stock options outstanding of 6,252,000 and 10,264,000, respectively, and additional warrant shares outstanding of 7,580,000 and 11,333,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method. For the first half ended April 30, 2013 and 2012, the shares used in computing diluted net loss per share do not include 3,814,000 and 3,979,000, respectively, of dilutive stock options and shares of restricted stock, nor 16,833,000 and 13,349,000, respectively, of dilutive warrant shares as the effect is anti-dilutive given the Company’s loss. For the first half ended April 30, 2013 and 2012, additional stock options outstanding of 6,936,000 and 10,556,000, respectively, and additional warrant shares outstanding of 8,821,000 and 12,305,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method.

The table below sets forth the reconciliation of the denominator of each net loss per share calculation:


	Fiscal year ended October 31,
In thousands	2012		2011		2010
Shares used in computing basic net loss per share		164,245		162,430		135,334
Dilutive effect of stock options and restricted stock⁽¹⁾		—		—		—
Dilutive effect of stock warrants⁽¹⁾		—		—		—

Shares used in computing diluted net income per share		164,245		162,430		135,334

⁽¹⁾

For fiscal 2012, 2011 and 2010, the shares used in computing diluted net loss per share do not include 3,103,000,4,887,000, and 4,099,000 dilutive stock options and shares of restricted stock, respectively, nor 11,559,000, 14,732,000, and 12,521,000 dilutive warrant shares respectively, as the effect is anti-dilutive given the Company’s loss. For fiscal 2012, 2011 and 2010, additional stock options outstanding of 10,559,000, 10,862,000, and 11,474,000, respectively, and additional warrant shares outstanding of 14,095,000, 10,922,000, and 13,133,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method.